Eat a meal with protein and carbs within 30 minutes of injection
Doctors consider a patients comorbidities (coexisting, often chronic health conditions), as well as their goals, lifestyle habits and risk factors when deciding which option to choose
This study, published in the New England Journal of Medicine (2016), showed that semaglutide reduced the risk of major adverse cardiovascular events compared to placebo, suggesting potential cardiovascular benefits rather than harm
Kurt Neumann, Independent Researcher, Kerkteleki, Hungary Updates Copyright 2019 van Campen, Riepma and Visser
For patients interested in combination therapy, switching from semaglutide to PlexusDx's Tirzepatide Injection or GLP-Squared Injection (which combines semaglutide and tirzepatide) typically occurs after the semaglutide dose levels drop sufficiently to avoid dual-overlap side effects